Colorimetric approach to high-throughput mutation analysis

BioTechniques

Volumn 38, Issue 4, 2005, Pages 635-639

  Benoit, Nicole E ^a   Goldenberg, David ^a   Deng, Shirley X ^b   Rosenbaum, Eli ^a   Cohen, Yoram ^a   Califano, Joseph A ^a   Shackelford, William H ^b   Wang, Xiao B ^b   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TrimGen Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CALORIMETRY; DENSITY (OPTICAL); GENETIC ENGINEERING; SENSITIVITY ANALYSIS; STATISTICAL METHODS; TUMORS;

GENOMIC MUTATION; HIGH-THROUGHPUT MUTATION ANALYSIS; OLIGONUCLEOTIDE; POLYMORPHISM;

MUTAGENESIS;

PROTEIN P53;

ACCURACY; ANALYTIC METHOD; ARTICLE; COLORIMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; GENE MUTATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; LUNG CANCER; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE; WILD TYPE;

EID: 17244375548     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/05384PF01     Document Type: Article

References (18)

1. Scully, R. and D.M. Livingston. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408:429-432.
2. Gretarsdottir, S., S. Thorlacius, R. Valgardsdottir, S. Gudlaugsdottir, S. Sigurdsson, M. Steinarsdottir, J.G. Jonasson, K. Anamthawat-Jonsson, and J.E. Eyfjord. 1998. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res. 55:859-862.
3. Pollock, P.M. and P.S. Meltzer. 2002. A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell 2:5-7.
4. Kimura, E.T., M.N. Nikiforova, Z. Zhu, J.A. Knauf, Y.E. Nikiforov, and J.A. Fagin. 2003. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 63:1454-1457.
5. Doolittle, B.R., J. Emanuel, C. Tuttle, and J. Costa. 2001. Detection of the mutated K-Ras biomarker in colorectal carcinoma. Exp. Mol. Pathol. 70:289-301.
6. Takahashi, T., M. Munakata, Y. Ohtsuka, H. Nisihara, Y. Nasuhara, A. Kamachi-Satoh, H. Dosaka-Akita, Y. Homma, and Y. Kawakami. 2002. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis. Cancer 95:624-633.
7. Hollstein, M., D. Sidransky, B. Vogelstein, and C.C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53.
8. Sidransky, D. and M. Hollstein. 1996. Clinical implications of the p53 gene. Annu. Rev. Med. 47:285-301.
9. Gross, E., N. Arnold, J. Goette, U. Schwarz-Boeger, and M. Kiechle. 1999. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum. Genet. 105:72-78.
10. Kahmann, S., P. Herter, C. Kuhnen, K.M. Muller, G. Muhr, D. Martin, M. Soddemann, and O. Muller. 2002. A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations. Hum. Mutat. 19:165-172.
11. Gite, S., M. Lim, R. Carlson, J. Olejnik, B. Zehnbauer, and K. Rothschild. 2003. A high-throughput nonisotopic protein truncation test. Nat. Biotechnol. 21:194-197.
12. Califano, J., P. van der Riet, W. Westra, H. Nawroz, G. Clayman, S. Piantadosi, R. Corio, D. Lee, et al. 1996. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56:2488-2492.
13. Brennan, J.A., L. Mao, R.H. Hruban, J.O. Boyle, Y.J. Eby, W.M. Koch, S.N. Goodman, and D. Sidransky. 1995. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 332:429-435.
14. Sidransky, D., A. Von Eschenbach, Y.C. Tsai, P. Jones, I. Summerhayes, F. Marshall, M. Paul, P. Green, et al. 1991. Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706-709.
15. Okuda, H., S. Fujii, and Y. Kawashima. 1965. A direct colorimetric determination of blood ammonia. Tokushima J. Exp. Med. 12:11-23.
16. Goldenberg, D., S. Harden, B.C. Masayesva, P. Ha, N. Benoit, W.U. Westra, W.M. Koch, D. Sidransky, and J.A. Califano. 2004. Intraoperative molecular margin analysis in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 130:39-44.
17. Cohen, Y., E. Rosenbaum, D.P. Clark, M.A. Zeiger, C.B. Umbricht, R.P. Tufano, D. Sidransky, and W.H. Westra. 2004. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin. Cancer Res. 10:2761-2765.
18. Cohen, Y., E. Rosenbaum, S. Begum, D. Goldenberg, C. Esche, O. Lavie, D. Sidransky, and W.H. Westra. 2004. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin. Cancer Res. 10:3444-3441.